Bioinformatics Analysis of Zinc-Alpha2-Glycoprotein，a Potential Serological Marker for Hepatocellualr Carcinoma

Abstract:

To Analyze the structure and function of Zinc-alpha-2-glycoprotein (ZAG), a highly expressed serum protein in the patients with hepatocellular carcinoma (HCC). The serum proteome of the patients from HCC, liver cirrhosis and healthy donors were separated and identified by two-dimensional electrophoresis and MALDI-TOF-MS. RT-PCR and Western blotting analysis were used to confirm ZAG highly expressed in HCC. Bioinformatics technologies were used to analyze the structure character of ZAG protein. Five differentially expressed proteins were identified. Albumin, Serotransferrin，CD5 antigen-like precursor ( IgM - associated peptide) were down-regulated in HCC, ZAG and Ig gamma-1 chain C region were up-regulated in HCC. Zinc-alpha-2-glycoprotein (ZAG), a lipid mobilizing factor, is a member of the major histocompatibility complex (MHC) class I family of protein. ZAG protein might be a potential serological biomarker for HCC early diagnosis.

• Periodical: Advanced Materials Research (Volume 340)
• Pages: 390-396
• DOI: https://doi.org/10.4028/www.scientific.net/AMR.340.390
• Online since: September 2011
• Authors: Fei Wang, Yu Geng, Wei Ming Zhang, Xin Geng
• Keywords: Hepatocellular Carcinoma, Proteome, Serological Biomarker, Zinc-Alpha-2-Glycoprotein

References

[1] Li Y, Geng X, Zhang W. Application of proteomics to the study of hepatocellular carcinoma and some related diseases. Chinese J Clinical Oncology 2(6), 903-906, (2005).

DOI: 10.1007/bf02789663

[2] Geng X, Wang F, Li YG, et al. SELDI-TOF MS ProteinChip technology for screening of serum markers of HBV-induced hepatocellular carcinoma. J Exp Clin Cancer Res. 26 (4), 505-508 , (2007).

DOI: 10.5353/th_b3639243

[3] Peng XQ, Wang F, Geng X, Zhang WM. Current advances in tumor proteomics and candidate biomarkers for hepatic cancer. Exp Rev Proteomics. 6 (5), 551-561, (2009).

DOI: 10.1586/epr.09.72

[4] Gong FY, Zhang SJ, Deng JY, et al. Zinc-alpha2-glycoprotein is involved in regulation of body weight through inhibition of lipogenic enzymes in adipose tissue. Int J Obes (Lond). 33(9): 1023-30, Sep (2009).

DOI: 10.1038/ijo.2009.141

[5] Mracek T, Ding Q, Tzanavari T, et al. The adipokine zinc-alpha2-glycoprotein is downregulated with fat mass expansion in obesity. Clin Endocrinol (Oxf). Jun (2009).

DOI: 10.1111/j.1365-2265.2009.03658.x

[6] Yeung DC, Lam KS, Wang Y, et al. Serum zinc-alpha2-glycoprotein correlates with adiposity, triglycerides, and the key components of the metabolic syndrome in Chinese subjects. J Clin Endocrinol Metab. 94(7): 2531-6 , Jul (2009).

DOI: 10.1210/jc.2009-0058

[7] Marrades MP, Martínez JA, Moreno-Aliaga MJ. ZAG, a lipid mobilizing adipokine, is downregulated in human obesity. J Physiol Biochem. 64(1): 61-6., Mar (2008).

DOI: 10.1007/bf03168235

[8] Huang YP, Cheng J, Zhang SL, Wang L, Guo J, Liu Y, et al. Screening of hepatocyte proteins binding to F protein of hepatitis C virus by yeast two-hybrid system. World J Gastroenterol 2005; 11: 5659–65.

DOI: 10.3748/wjg.v11.i36.5659

[9] Hale LP, Price DT, Sanchez LM, Demark-Wahnefried W, Madden JF. Zinc alpha-2-glycoprotein is expressed by malignant prostatic epithelium and may serve as a potential serum marker for prostate cancer. Clin Cancer Res; 7: 846–53, (2001).

[10] Susan M. Henshall , Lisa G. Horvath, et al. Zinc-alpha2-glycoprotein Expression as a Predictor of Metastatic Prostate Cancer Following Radical Prostatectomy. J Natl Cancer Inst; 98: 1420 – 11424, (2006).

DOI: 10.1093/jnci/djj378